Long
Updated

Buy $ACOR - NRPicks 12 Nov

203
Acorda Therapeutics, Inc. a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company markets Ampyra , an oral medication to improve gait in patients with multiple sclerosis (MS).
Trade closed: stop reached
Nov 22

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.